Health
What are the risks associated with human challenge trials for SARS-CoV-2 vaccine candidates? – News-Medical.Net
Researchers from the University of Haifa, Israel, and WAW Statistical Consulting Ltd, UK, designed a model that helps determine the risks faced by participants…
The timely development of preventive vaccines and new therapeutic drugs will be crucial in managing the burden caused by the coronavirus disease 2019 (COVID-19) pandemic. While there are no approved vaccines for COVID-19 currently, as per estimates, global vaccine production will reach 8 billion doses by 2021, assuming the best vaccine candidate passes clinical trials as expected.
Traditional clinical trials are time-consuming and need a large number of subjects to detect the therapeutic effects…
-
Noosa News7 hours agoHow Lily Steele-Park took her rapist to court and won
-
General21 hours ago‘Potential’ hacker contacts Qantas over data breach
-
Business12 hours agoFord CEO makes stunning prediction about artificial intelligence
-
General23 hours agoFears for next anti-Semitic firebombing on home soil